Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica
|
April 29, 2005
[Genetically modified animals as models for psychiatric diseases]
Ichiro Sora, Hideaki Kobayashi, Yotaro Numachi
Brain & Development
|
November 1, 2015
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: A multi-center, uncontrolled, open-label study
Sawa Yasumoto, Masahiro Shimizu, Katsuaki Sato, et al.
Parkinsonism & Related Disorders
|
April 27, 2017
Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease
Nobutaka Hattori, Kazuko Hasegawa, Katsuaki Sato, et al.
Clinical Pharmacology in Drug Development
|
June 6, 2018
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers
Hiroko Ino, Akira Endo, Akira Wakamatsu, et al.
Brain & Development
|
June 5, 2018
Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study
Sawa Yasumoto, Yoko Ohtsuka, Katsuaki Sato, et al.
Clinical Pharmacology in Drug Development
|
October 11, 2018
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects
Hiroko Ino, Robert Wilson, Takumi Terao, et al.
Clinical Pharmacology in Drug Development
|
April 7, 2020
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
Masanori Yamada, Minori Osamura, Hirofumi Ogura, et al.
Clinical Pharmacology in Drug Development
|
January 18, 2020
Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry
Takayuki Iida, Romina A Nand, Hiroko Ino, et al.
Headache
|
March 25, 2021
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Clinical Pharmacology in Drug Development
|
May 7, 2019
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants
Takayuki Iida, Yuki Matsuzawa, Hirofumi Ogura, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica
|
April 29, 2005
[Genetically modified animals as models for psychiatric diseases]
Ichiro Sora, Hideaki Kobayashi, Yotaro Numachi
Brain & Development
|
November 1, 2015
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: A multi-center, uncontrolled, open-label study
Sawa Yasumoto, Masahiro Shimizu, Katsuaki Sato, et al.
Parkinsonism & Related Disorders
|
April 27, 2017
Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease
Nobutaka Hattori, Kazuko Hasegawa, Katsuaki Sato, et al.
Clinical Pharmacology in Drug Development
|
June 6, 2018
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers
Hiroko Ino, Akira Endo, Akira Wakamatsu, et al.
Brain & Development
|
June 5, 2018
Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study
Sawa Yasumoto, Yoko Ohtsuka, Katsuaki Sato, et al.
Clinical Pharmacology in Drug Development
|
October 11, 2018
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects
Hiroko Ino, Robert Wilson, Takumi Terao, et al.
Clinical Pharmacology in Drug Development
|
April 7, 2020
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
Masanori Yamada, Minori Osamura, Hirofumi Ogura, et al.
Clinical Pharmacology in Drug Development
|
January 18, 2020
Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry
Takayuki Iida, Romina A Nand, Hiroko Ino, et al.
Headache
|
March 25, 2021
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Clinical Pharmacology in Drug Development
|
May 7, 2019
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants
Takayuki Iida, Yuki Matsuzawa, Hirofumi Ogura, et al.
Page
of 2